Filing Flows

Filing Flows › Companies › Foghorn Therapeutics › Timeline

Foghorn Therapeutics stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions−53.3% to $1.87

Foghorn Therapeutics (FHTX) stock fell 53% over the last 252 sessions, to $1.87. On the way it reported 3 quarters, its insiders filed no open-market trades (10b5-1 plan sales aside), and the company filed 3 material 8-Ks. Each is marked on the price and listed with what the stock did next.

FHTX: a year of the stock with every disclosure on itFHTX: a year of the stock with every disclosure on it$2.95$4.46$5.97$7.49◆2025-12-04 · Directors and officers: departures, appointments, pay◆2026-02-23 · Directors and officers: departures, appointments, pay●2026-03-11 · Earnings: missed the EPS estimate by -42.4%●2026-05-07 · Earnings: beat the EPS estimate by 7.2%●2026-08-06 · Earnings: beat the EPS estimate by 57.1%◆2026-10-01 · Exit or disposal costs◆8-K event●Earnings report2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Oct 1, 20268-KExit or disposal costs−20.1% (−20.3% vs SPY)−53.5% (−55.4% vs SPY)−53.5% (−54.4% vs SPY)
Aug 6, 2026EarningsEarnings: beat the EPS estimate by 57.1%+13.2% (+13.4% vs SPY)+30.8% (+30.5% vs SPY)−0.2% (−0.6% vs SPY)
May 7, 2026EarningsEarnings: beat the EPS estimate by 7.2%−10.8% (−10.5% vs SPY)−11.5% (−12.7% vs SPY)−22.7% (−23.2% vs SPY)
Mar 11, 2026EarningsEarnings: missed the EPS estimate by -42.4%+2.9% (+3.0% vs SPY)−8.2% (−7.2% vs SPY)−13.7% (−14.3% vs SPY)
Feb 23, 20268-KDirectors and officers: departures, appointments, pay+0.4% (+1.4% vs SPY)−0.9% (−0.4% vs SPY)−11.9% (−7.0% vs SPY)
Dec 4, 20258-KDirectors and officers: departures, appointments, pay+3.1% (+3.0% vs SPY)+0.2% (−0.3% vs SPY)+11.5% (+10.6% vs SPY)

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
2.05 Exit or disposal costs954−0.2%47%+0.5%±2.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Foghorn Therapeutics: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.